Skip to contentNEWRetatrutide beat Ozempic head to head in TRANSCEND-T2D-2. What the sixth Phase 3 trial found
Retatrutide360

Medical Review Process

Last updated September 27, 2026

We want you to know exactly who has checked what you read. Every clinical claim on Retatrutide360 is vetted against primary scientific literature and reviewed by licensed medical professionals.

Our medical reviewer

Medical review on Retatrutide360 is led by Dr. Juan Pablo Frías, MD, a physician-scientist specializing in endocrinology, diabetes, and metabolism. Dr. Frías completed his fellowship in Endocrinology, Diabetes, and Metabolism at the University of California, San Diego, and has served as principal investigator on major clinical trials evaluating retatrutide, tirzepatide, and semaglutide.

Read his full background, clinical appointments, and publication record on his physician bio page.

The four-step medical review process

Every guide published on Retatrutide360 goes through a structured clinical verification process:

  1. Source verification: Writers link every clinical number, percentage, and timeline to primary studies (such as the New England Journal of Medicine or The Lancet) or official trial registries.
  2. Clinical pharmacology review: Dr. Frías checks that receptor mechanisms (GIP, GLP-1, and glucagon), dosing titrations, and reconstitution protocols reflect established clinical trial protocols.
  3. Safety and adverse event audit: Reported side effect rates (including nausea, digestive symptoms, and transient pulse increases) are checked against actual trial safety tables.
  4. Post-trial updates: When new clinical trial readouts land (such as Phase 3 TRIUMPH trial results), affected guides are promptly audited and updated with new data and a revised review date.

What the "Medically reviewed by" line means

When you see "Medically reviewed by Dr. Juan Pablo Frías" at the top of a page, it confirms that:

  • A licensed endocrinologist and clinical trialist has examined the clinical statements on the page.
  • The dosing tables, titration schedules, and syringe measurements adhere to trial protocols.
  • Potential risks and contraindications are accurately stated.

What that means for you

Treat every guide as a well-sourced starting point for a conversation with your own doctor, not as a substitute for individualized clinical care. Retatrutide remains an investigational agent in clinical development. Our medical disclaimer covers this in more detail.